Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers
<i>Background and objectives:</i> Interleukin-7 (IL-7) is exploited in cancer immunotherapies although its status in solid tumors is largely unknown. We aimed to determine its systemic and local concentrations in esophageal (EC), gastric (GC), and colorectal (CRC) cancers. <i>Mater...
Main Authors: | Iwona Bednarz-Misa, Dorota Diakowska, Małgorzata Krzystek-Korpacka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/6/262 |
Similar Items
-
Interleukins 4 and 13 and Their Receptors Are Differently Expressed in Gastrointestinal Tract Cancers, Depending on the Anatomical Site and Disease Advancement, and Improve Colon Cancer Cell Viability and Motility
by: Iwona Bednarz-Misa, et al.
Published: (2020-06-01) -
Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study
by: Ito Hiroaki, et al.
Published: (2013-01-01) -
Lymph Node Metastasis of Gastric Cancer
by: Seigo Kitano, et al.
Published: (2011-04-01) -
Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
by: Ding-Kang Wang, et al.
Published: (2021-08-01) -
Evaluation of metastatic lymph nodes in cN0 thoracic esophageal cancer patients with inconsistent pathological lymph node diagnosis
by: Akiyuki Wakita, et al.
Published: (2020-05-01)